ArticleFrontiers in aging neuroscience2026
Age-dependent vulnerability to spatial memory interference in APP/PS1 mice.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While Alzheimer's disease (AD) is well known for progressive memory impairment, less is understood about how amyloid pathology affects flexible updating of competing spatial representations. Here, we used the Objects in Updated Locations (OUL) paradigm to investigate how amyloidosis influences spatial memory updating and the handling of competing mnemonic information in APP/PS1 mice. Methods: APP/PS1 and wild-type control mice were tested in the OUL paradigm, which probes memory for object displacement and subsequent updating of overlapping spatial representations. Exploration behavior was quantified using an automated behavioral tracking pipeline based on object proximity and gaze orientation criteria and validated against blinded manual scoring. Object discrimination performance was assessed during the object displacement session and during the subsequent updating performance session involving competing spatial information. cFos immunohistochemistry following novelty exposure was used to assess neuronal recruitment associated with memory performance. Results: During the object displacement session, control mice reliably discriminated the displaced object location, whereas APP/PS1 mice showed weaker and more variable performance, with a greater proportion failing to reach discrimination criterion levels. During the subsequent updating performance session, control mice demonstrated more flexible adaptation across overlapping spatial representations, while APP/PS1 mice exhibited weaker performance under conditions involving competing spatial traces. In APP/PS1 mice, longer exploration latencies were negatively associated with discrimination performance specifically under competing-memory conditions. Age-stratified analyses revealed a significant genotype effect in older animals, driven primarily by the condition involving overlapping spatial representations. In control mice, cFos expression in hippocampal regions associated with spatial memory processing correlated with behavioral performance, whereas these relationships were absent in APP/PS1 mice. Conclusion: These findings indicate that amyloidosis is associated with reduced reliability of spatial memory performance and impaired handling of competing spatial information, particularly under conditions requiring flexible updating of overlapping mnemonic representations. The results further suggest increased vulnerability to interference-related spatial memory deficits with age. Together, these findings support the utility of the OUL paradigm for studying memory updating impairments in AD-related pathology and identify flexible spatial updating under interference as a sensitive behavioral domain affected by amyloidosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.